R&D expense · 2019–2025
Universe Pharmaceuticals R&D expense
$672M−77.8% · FY2025
Universe Pharmaceuticals (UPC) reported $672M in R&D expense for fiscal 2025, −77.8% year on year.
| Fiscal year | R&D expense | Change | Filing |
|---|---|---|---|
| FY20252025-09-30 | $672M | −77.8% | Open → |
| FY20242024-09-30 | $3.0B | −37.6% | Open → |
| FY20232023-09-30 | $4.9B | +63,457.2% | Open → |
| FY20222022-09-30 | $7.6M | +39.9% | Open → |
| FY20212021-09-30 | $5.5M | +837.3% | Open → |
| FY20202020-09-30 | $583,125 | −5.7% | Open → |
| FY20192019-09-30 | $618,437 | — | Open → |
R&D expense — Research and development expense is what the company charged to R&D in the income statement for the year. Most companies report no R&D at all — the line is absent rather than zero — so this ranking covers the roughly 40% of filers that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2025 compound annual growth +220.6%
R&D expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Universe Pharmaceuticals R&D expense |url=https://companiesranked.com/en/company/universe-pharmaceuticals/research-and-development-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Universe Pharmaceuticals R&D expense. CompaniesRanked. https://companiesranked.com/en/company/universe-pharmaceuticals/research-and-development-expenseBibTeX
@misc{companiesranked-en-company-universe-pharmaceuticals-research-and-development-expense-2026,
author = {{CompaniesRanked}},
title = {{Universe Pharmaceuticals R\&D expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/universe-pharmaceuticals/research-and-development-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001213900-26-009000 · January 29, 2026
{{cite web |title=Universe Pharmaceuticals R&D expense — 20-F (0001213900-26-009000) |url=https://www.sec.gov/Archives/edgar/data/1809616/000121390026009000/ea0273969-20f_universe.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-01-29}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.